Indication
Recurrent Nodular Sclerosis Classical Hodgkin Lymphoma
1 clinical trial
2 products
2 drugs
Clinical trial
Phase II Trial of Pembrolizumab in Combination With ICE Salvage Chemotherapy for Relapsed/Refractory Hodgkin LymphomaStatus: Active (not recruiting), Estimated PCD: 2020-12-30
Drug
AN0025Product
EtoposideProduct
IfosfamideDrug
mFOLFOX6